Necessity of high dose and prolonged duration denosumab post stem cell transplant for TNFRSF11A osteoclast-poor autosomal recessive osteopetrosis
Tashunka Taylor-Miller,Hemalatha Doss,Heather Weerdenburg,Sam Whiting,Ponni Sivaprakasam,Adam Gassass,Sarah F Smithson,Colin G Steward,Christine P Burren
